CareSignal (formerly Epharmix) offers interventions that use automated phone calls or text messages to manage patients’ conditions while collecting disease-specific data. Epharmix interventions align with value metrics and reimbursement opportunities.

Lighbeam health acquire CareSignal in November 2021.

For more information, visit CareSignal or follow their updates on:

Financials

  • $7.5m

CareSignal Articles

CareSignal Acquired by Lightbeam Health Solutions

EQ Staff, Jonathan Allen
< 1 Min Read

Epharmix Rebrands To CareSignal

EQ admin
< 1 Min Read

CareSignal Raises $7M to Expand Nationally

EQ admin
< 1 Min Read

St. Louis Startup Milestones Reached in 2018

EQ Staff, Jonathan Allen
3 Min Read

It Takes a Village (and Universities Directly Engaging the Startup Ecosystem) to Retain Talent in St. Louis

Jonathan Allen
4 Min Read

Trends in Life Science and Healthcare Innovation

EQ Staff, Jonathan Allen
4 Min Read

#CEO2CEO: Blake Marggraff of Epharmix and Anthony Tersigni of Ascension on Healthcare Technology

EQ Staff, Jonathan Allen
6 Min Read

Epharmix Teams Up with Provident on Suicide Prevention Tools

EQ Staff, Jonathan Allen
2 Min Read

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

EQ Staff, Jonathan Allen
4 Min Read

Founder Series: Blake Marggraff of Epharmix

EQ Staff, Jonathan Allen
6 Min Read